Clinical Study
The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
Table 4
Bivariate analysis was used to determine which of the above factors was more likely to prompt physicians to screen for osteoporosis.
| | Odds ratio | 95% CI |
| Number of ADT treatments | 1.24 | 1.096–1.403 | Age | 0.73 | 0.911–1.040 | Gleason score | 1.082 | 0.687–1.703 | Years since diagnosis | 1.109 | 0.915–1.345 | Smoking history | 1.43 | 0.565–3.621 | Stage 1 A or B or C versus Stage 3 A or B or C | 0.959 | 0.264–3.484 | Stage 2 A or B or C versus Stage 3 A or B or C | 1.61 | 0.539–4.808 |
|
|